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The adequate management of analgosedation and delirium is related to better outcomes in intensive care units. (1) (2) (3) The objective of this study is to evaluate the current status of the management of analgosedation and delirium in Brazil.
A questionnaire was developed on the SurveyMonkey ® (Appendix 1) digital platform with 15 multiple-choice questions, among which some of the questions had only one option while others could have more than one option. The instrument was made available from November 2015 to February 2016. The method of selection of professionals for data collection included several multiprofessional categories.
A total of 410 professionals answered the questionnaire. Of these, 48.78% worked in public hospitals, 33.41% in private hospitals, and 17.80% in philanthropic hospitals. A total of 81.23% professionals worked in an intensive care unit (ICU) with a general profile.
The results indicated that 59.50% of the respondents used analgosedation protocols in their services, which is slightly higher than that found by Salluh et al. (4) but lower than that found by Patel et al., (5) wherein 71% of the study participants used analgosedation protocols.
Among the study participants, 234 (59.24%) reported performing a systematic evaluation of pain in their ICU. Pain was evaluated up to twice a day for 35.48% of the sample, and the nurse and physician were responsible for these evaluations in most cases (51.34% and 42.78%, respectively). Sedation was evaluated up to twice a day in 49.35% of cases.
With respect to the management of sedation, validated tools (Richmond Agitation-Sedation Scale -RASS and Sedation-Agitation Scale -SAS) were used by 72.91% of the respondents, and the most commonly used sedation strategies were daily awakening (60.11%) and targeted sedation (23.94%). There was a high rate of use of validated tools (12%) compared with national data from 2009. (4) The availability of analgosedation in services and its incorporation in protocols was evaluated. Midazolam, fentanyl, propofol, and morphine were the most available drugs in the analyzed institutions. The first three drugs, in addition to dexmedetomidine, were the most used in institutional protocols. The use of these drugs is common despite recommendations to avoid the use of benzodiazepines in the choice of sedative drugs. A total of 44.68% of the respondents evaluated delirium systematically. Of these, 56.72% used the Confusion Assessment Method for the ICU (CAM-ICU), and 37.37% did not use a validated tool. In the study by Patel et al., 59% of respondents systematically assessed delirium. (5) Of the total sample, 29.62% evaluated delirium daily, and 23.10% performed evaluations twice a day. Physicians and nurses conducted these evaluations in 64.07% and 26.05% of cases, respectively. Haloperidol was the drug of choice for managing hyperactive delirium for 72.13% of participants. In addition, 12.30% of respondents used dexmedetomidine, and 11.20% used antipsychotics ( Table 1) .
The limitations of the study were the lack of consideration of the geographical distribution of the ICUs of respondents, lack of differentiation of responses between public, private, and philanthropic hospitals, and lack of comparison of responses among multiprofessional teams.
In conclusion, this study reveals the need to advance the routines used in the management of analgosedation and delirium, despite consistent evidence for improved outcomes in the literature when the recommended protocols and strategies are used. 
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